Stay updated on Xilonix for Symptomatic Colorectal Cancer: Clinical Trial
Sign up to get notified when there's something new on the Xilonix for Symptomatic Colorectal Cancer: Clinical Trial page.

Latest updates to the Xilonix for Symptomatic Colorectal Cancer: Clinical Trial page
- Check3 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing Revision: v3.3.3. This is a minor metadata update and does not change study content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedFooter updates show Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedThe Publications section now specifies that listed publications are about the results of the study, and the revision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the general government funding status notice from the page, a site-wide banner that does not affect the study details, eligibility criteria, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedBoth screenshots display the same study page with the core details (title, NCT number, eligibility criteria, and outcomes) unchanged. The differences appear to be visual/layout changes that do not alter the page’s substantive content.SummaryDifference0.4%

- Check103 days agoChange DetectedUpdated page now includes a government-operating-status notice and a new 3.2.0 revision, replacing the prior 3.1.0 revision.SummaryDifference4%

Stay in the know with updates to Xilonix for Symptomatic Colorectal Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Xilonix for Symptomatic Colorectal Cancer: Clinical Trial page.